These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
595 related articles for article (PubMed ID: 26126877)
1. IVF for fertility preservation in breast cancer patients--efficacy and safety issues. Shapira M; Raanani H; Meirow D J Assist Reprod Genet; 2015 Aug; 32(8):1171-8. PubMed ID: 26126877 [TBL] [Abstract][Full Text] [Related]
2. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies. Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489 [TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review. Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356 [TBL] [Abstract][Full Text] [Related]
4. BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles. Shapira M; Raanani H; Feldman B; Srebnik N; Dereck-Haim S; Manela D; Brenghausen M; Geva-Lerner L; Friedman E; Levi-Lahad E; Goldberg D; Perri T; Eldar-Geva T; Meirow D Fertil Steril; 2015 Nov; 104(5):1162-7. PubMed ID: 26335130 [TBL] [Abstract][Full Text] [Related]
5. Fertility preservation options in breast cancer patients. Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157 [TBL] [Abstract][Full Text] [Related]
6. Fertility after breast cancer treatment. Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568 [TBL] [Abstract][Full Text] [Related]
7. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients. Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617 [TBL] [Abstract][Full Text] [Related]
8. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients. Michaan N; Ben-David G; Ben-Yosef D; Almog B; Many A; Pauzner D; Lessing JB; Amit A; Azem F Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):175-7. PubMed ID: 20074845 [TBL] [Abstract][Full Text] [Related]
9. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy. Danis RB; Pereira N; Elias RT Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354 [TBL] [Abstract][Full Text] [Related]
10. Controlled ovarian stimulation outcomes of fertility preservation procedures in newly diagnosed breast cancer patients: a retrospective study from a single-tertiary-IVF centre. Sahin G; Goker ENT; Gokmen E; Yeniay L; Acet F; Zekioglu O; Tavmergen E J Obstet Gynaecol; 2022 Apr; 42(3):518-523. PubMed ID: 34382483 [TBL] [Abstract][Full Text] [Related]
13. COH outcomes in breast cancer patients for fertility preservation: a comparison with the expected response by age. Malacarne E; Devesa M; Martinez F; Rodriguez I; Coroleu B J Assist Reprod Genet; 2020 Dec; 37(12):3069-3076. PubMed ID: 32945994 [TBL] [Abstract][Full Text] [Related]
14. Fertility preservation and preimplantation genetic assessment for women with breast cancer. Sciorio R; Anderson RA Cryobiology; 2020 Feb; 92():1-8. PubMed ID: 31863734 [TBL] [Abstract][Full Text] [Related]
15. Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer. Porcu E; Cillo GM; Cipriani L; Sacilotto F; Notarangelo L; Damiano G; Dirodi M; Roncarati I J Assist Reprod Genet; 2020 Mar; 37(3):709-715. PubMed ID: 31872386 [TBL] [Abstract][Full Text] [Related]
16. Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes. Turan V; Bedoschi G; Emirdar V; Moy F; Oktay K Reprod Sci; 2018 Jan; 25(1):26-32. PubMed ID: 28874104 [TBL] [Abstract][Full Text] [Related]
17. Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience. Cardozo ER; Thomson AP; Karmon AE; Dickinson KA; Wright DL; Sabatini ME J Assist Reprod Genet; 2015 Apr; 32(4):587-96. PubMed ID: 25595540 [TBL] [Abstract][Full Text] [Related]
18. The case for aromatase inhibitors use in oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in breast cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate. Fatum M; McVeigh E; Child T Hum Fertil (Camb); 2013 Dec; 16(4):235-40. PubMed ID: 23863119 [TBL] [Abstract][Full Text] [Related]
19. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. Oktay K; Buyuk E; Libertella N; Akar M; Rosenwaks Z J Clin Oncol; 2005 Jul; 23(19):4347-53. PubMed ID: 15824416 [TBL] [Abstract][Full Text] [Related]
20. Live birth using vitrified--warmed oocytes in invasive ovarian cancer: case report and literature review. Alvarez M; Solé M; Devesa M; Fábregas R; Boada M; Tur R; Coroleu B; Veiga A; Barri PN Reprod Biomed Online; 2014 Jun; 28(6):663-8. PubMed ID: 24745835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]